182 related articles for article (PubMed ID: 38692300)
1. CAR T-Cell Therapy in Autoimmune Disease. Reply.
Müller F; Mackensen A; Schett G
N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
[No Abstract] [Full Text] [Related]
2. CAR T-Cell Therapy in Autoimmune Disease.
Howard JF; Vu T; Mozaffar T
N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
[No Abstract] [Full Text] [Related]
3. CAR T-Cell Therapy in Autoimmune Disease.
Merkt W; Lorenz HM; Schmitt M
N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
[No Abstract] [Full Text] [Related]
4. CAR T-Cell Therapy in Autoimmune Disease.
De Benedetti F; Diomedi Camassei F; Locatelli F
N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
[No Abstract] [Full Text] [Related]
5. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
Lyu X; Gupta L; Tholouli E; Chinoy H
Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
[TBL] [Abstract][Full Text] [Related]
6. Dawn of CAR-T cell therapy in autoimmune diseases.
Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
[TBL] [Abstract][Full Text] [Related]
7. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
[TBL] [Abstract][Full Text] [Related]
8. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
Radic M; Neeli I; Marion T
Expert Opin Biol Ther; 2022 Apr; 22(4):499-507. PubMed ID: 35089116
[TBL] [Abstract][Full Text] [Related]
9. CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?
van Leuven SI; Duivenvoorden R
Rheumatology (Oxford); 2024 May; 63(5):1192-1194. PubMed ID: 38377390
[No Abstract] [Full Text] [Related]
10. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
Zhang PF; Xie D; Li Q
Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
[TBL] [Abstract][Full Text] [Related]
11. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
Daamen AR; Lipsky PE
Ann Rheum Dis; 2024 May; 83(6):696-699. PubMed ID: 38637134
[TBL] [Abstract][Full Text] [Related]
12. CAR T-cell therapy in autoimmune diseases.
Schett G; Mackensen A; Mougiakakos D
Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
[TBL] [Abstract][Full Text] [Related]
13. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
Santamaria-Alza Y; Vasquez G
Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
Ghassemi S; Milone MC
J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
[TBL] [Abstract][Full Text] [Related]
15. CAR T cells for infection, autoimmunity and allotransplantation.
Maldini CR; Ellis GI; Riley JL
Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
Chen Y; Sun J; Liu H; Yin G; Xie Q
J Immunol Res; 2019; 2019():5727516. PubMed ID: 32083141
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
[TBL] [Abstract][Full Text] [Related]
18. New therapies in development for autoimmune diseases: their rationale for combination treatment.
Strand V
Springer Semin Immunopathol; 2001; 23(1-2):43-61. PubMed ID: 11455860
[No Abstract] [Full Text] [Related]
19. [CAR-T therapy for autoimmune diseases].
Alcaraz-Serna A; Porret R; Trueb L; Ribi C; Seebach J; Muller YD
Rev Med Suisse; 2024 Apr; 20(868):688-693. PubMed ID: 38568061
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity.
Sosnoski HM; Posey AD
Cell Stem Cell; 2024 Apr; 31(4):437-438. PubMed ID: 38579681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
